Artwork

Innehåll tillhandahållet av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Ep71: Learning from AI: Lessons for Digital Therapeutic Pioneers

34:47
 
Dela
 

Manage episode 372830575 series 2857558
Innehåll tillhandahållet av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episoder

Artwork
iconDela
 
Manage episode 372830575 series 2857558
Innehåll tillhandahållet av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episoder

Tous les épisodes

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide